SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-051369
Filing Date
2017-08-11
Accepted
2017-08-11 16:20:33
Documents
6
Period of Report
2017-08-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-20085_18k.htm 8-K 41538
2 EX-1.1 a17-20085_1ex1d1.htm EX-1.1 323200
3 EX-5.1 a17-20085_1ex5d1.htm EX-5.1 25569
4 EX-8.2 a17-20085_1ex8d2.htm EX-8.2 24720
5 EX-99.1 a17-20085_1ex99d1.htm EX-99.1 9899
6 GRAPHIC g200851mmi001.jpg GRAPHIC 11953
  Complete submission text file 0001104659-17-051369.txt   437384
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 171025400
SIC: 2834 Pharmaceutical Preparations